Cue Biopharma, Inc. (CUE) key performance indicators and operating metrics (4 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Total Operating Expenses | 9.74M | FY2025-Q3 |
| Median Overall Survival | 32.70 | FY2025-Q3 |
| Objective Response Rate | 50.00 percent | FY2025-Q3 |
| Twelve-Month Overall Survival | 88.00 percent | FY2025-Q3 |
Back to CUE overview · CUE earnings · CUE holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.